Backgrounds/Aims: Routine bile duct resection as part of the typical oncological resection for patients with advanced gallbladder cancer remains controversial with regard to, ultimately, curative value. The aim of this study was to compare oncological outcomes for patients undergoing surgery for gallbladder cancer with or without bile duct resection. Methods: We recruited, for the purpose of this study, all patients who underwent surgical resection for T2 and T3 gallbladder cancer at Severance hospital, Seoul, Korea, during the period January 2000 and December of 2011. The patient data was reviewed retrospectively. Results: The patients (n=149) recruited to participate in the study were divided into two groups according to their bile duct resection status: The bile duct resection group (BDR group, n=54); and, the bile duct non-resection group (BDNR group, n=95). Significant difference was found in lymph node retrieval between BDR and BDNR groups (15 vs. 5, respectively with p＜0.001). There was no significant difference between the two groups with regard to the five year survival rate (43% in BDR group vs. 57% in BDNR group, p=0.339). Following multivariate analysis, lymph node metastasis, advanced T-stage, and total retrieved lymph nodes ＜6 were independent prognostic factors for poor survival in patients with T2 and T3 gallbladder cancer. Conclusions: The findings revealed by the current study suggest that the role of bile duct resection might be limited to improved staging, and offers no advantage in long-term survival. However, in view of the foregoing and given the minimal increase in morbidity associated with BDR, it should be actively considered as a treatment option for patients who present with findings suspicious for invasion around hepatoduodenal ligament. (Ann Hepatobiliary Pancreat Surg 2018;22:42-51)
INTRODUCTION
Gallbladder adenocarcinoma, historically, has been considered an incurable malignancy with a dismal prognosis. 1, 2 Complete surgical resection seems to represent the only potentially effective curative treatment for resectable gallbladder cancer. Regional lymph node dissection is indispensable and invaluable for the accurate staging of gallbladder cancer. 3, 4 The extent of resection in gallbladder cancer is usually determined by the pre-and intraoperative assessment of the nature and extent of the tumor invasion.
According to the National Comprehensive Cancer Network (NCCN) guidelines, 5 simple cholecystectomy is considered appropriate to treat T1a gallbladder cancer. In patients with more advanced localized disease, en bloc hepatic resection and lymphadenectomy are recommended. 5 Whether routine bile duct resection is medically indicated and "should be performed", in many cases, remains a judgment call on the part of the surgeon because the surgical indication may remain unclear, even to direct inspection.
There is a lack of objective evidence to support an increased long-term survival rate after routine resection, while increased morbidity has been reported. [6] [7] [8] Several recent studies have focused on identifying prognostic factors conductive to long-term survival in those patients afflicted with advanced gallbladder cancer. Although several varia-bles such as lymphovascular invasion, the operative method and total lymph node count of ＜6 have been proposed no definitive consensus has ever been achieved. 3, 9, 10 Current guidelines 5 suggest that a selective approach to bile duct resection be implemented and utilized, with the aim of ensuring a negative margin. Despite the relative paucity of rarified, substantial medical evidence, others recommend routine bile duct resection in an effort to increase chances of disease-free survival. 9 The aim of this study was to more precisely assess and identify the role of bile duct resection for T2 and T3 gallbladder cancer, vis-à-vis the specific issues of oncological and long-term survival benefit. Dissection of para-aortic lymph nodes and other nodes belonging to the N2 group were usually conducted when lymph node enlargement was observed intraoperatively.
MATERIALS AND METHODS

Patients
Para-aortic lymph nodes were excluded from the total lymph node count. The nature and extent of additional or 
Statistical analysis
RESULTS
Of the 271 patients who underwent surgery for gallbladder cancer within the study period, 211 (78%) patients underwent R0 resection. Of these 211 patients, 149 (55%) had T2 or T3 disease confirmed pathologically and were included for further analysis (Fig. 1 ).
Clinicopathologic characteristics of patients divided into BDR group and BDNR group are summarized in Table   1 . Eighty-nine patients (60%) received liver resection; of these subjects, 73 (49%) received partial or complete resection of segment 4b/5. Trisectionectomy was performed in eight patients (5%), central bisectionectomy in three patients (2%) and hemihepatectomy in five patients (3%).
Combined resection of adjacent organs was performed in six patients (4%) of BDR group and included the pancreas (n=3), duodenum (n=1), and colon (n=2) (Fig. 2) . Of the 50 patients with T3 tumors, invasion into the liver (n=30), serosa (n=17) and bile duct (n=3) were diagnoseded and documented.
The median follow-up period for BDR group was 50 months (range: 0-145 months) and for BDNR group was 80 months (range: 0-152 months). During the follow-up period, recurrence occurred in 64 patients (43%). Local recurrences (n=8) occurred at the liver resection margin (n=4), hilar area (n=3) and trocar site (n=1).
Given the clinicopathologic heterogeneity (Table 1) among the two groups, a subgroup analysis was performed for those who underwent liver resection (n=89) with or without BDR ( According to the survival analysis for bile duct resection, there was no evidence of survival benefit of bile duct resection in each of cancer stage (Fig. 4) . Further survival analysis for liver resected patients has also shown no significant role of bile duct resection in both overall survival and disease-free survival (Fig. 5) .
In univariate analysis for disease-free survival, bile duct resection (p=0.048) was one indicator of poor survival outcome. However, in multivariate analyses, lymph node (Table 3 ). In multivariate analysis for overall survival, lymph node metastasis, T3 stage, and the total number of retrieved lymph nodes ＜6 were the independent prognostic factors of poor survival outcome (Table 4) .
DISCUSSION
The optimal extent of resection in advanced gallbladder cancer patients remains a debated issue. Chiefly, the clinical significance of concomitant bile duct resection remains controversial. Kokudo et al. 7 reported no appreciable survival benefit secondary to bile duct resection in patients with LN metastasis. Sakamoto et al. 8 also reported that there was no perceptible survival benefit associated with bile duct resection in patients with ≥T2 gallbladder cancer. Araida et al. 6 analyzed 838 gallbladder cancer patients and reported that no survival difference resulted from bile duct resection in patients without direct infiltration of the hepatoduodenal ligament.
In the current study, there were no significant, docu- Adequate LN assessment is important in patients with gastrointestinal cancers, 12-14 because insufficient lymph node dissection during surgery impedes accurate staging.
Ito et al. 3 reported that the minimum LN requirement for adequate gallbladder cancer staging was six nodes. In our study, the LN count of ＜6 was also the prognostic factor for poor survival outcome in gallbladder cancer patients (T2 and T3 stage) who received R0 resection. The BDR group had more LNs removed than the BDNR group.
Specifically, the LNs around the retropancreatic area were more frequently retrieved in the BDR group. Although bile duct resection did not affect the overall survival of gallbladder cancer patients, bile duct resection could be helpful for more accurately staging the disease.
Anatomically, the lymphatics around the hepatoduodenal ligament are the first lymphatic channels draining the gallbladder. 15 Tumor cell-spread into the hepatoduodenal ligament is very frequently observed in advanced gallbladder cancer. In 2014, pathologists in Japan reported 70.6% lymphatic/venous/perineural invasion of gallbladder Yes (54) 
＜0.001
HR, hazard ratio; 95% CI, 95% confidence interval; WD, well differentiated; MD, moderately differentiated; PD, poorly differentiated; Pos., positive; Neg., negative cancer (T2 and T3). 16 In our study, the BDR group had more lymph nodes retrieved around the retropancreatic area vs. the BDNR group. While other lymph node stations did not yield more retrieved lymph nodes for the BDR group, total number of lymph nodes retrieved was significantly higher in the BDR group. These results indicate that lymph node dissection with bile duct resection allow more thorough removal of lymph nodes without leaving remnant lymph nodes and connective tissue around the hepatoduodenal ligament.
Gallbladder cancer can spread in a skipped manner. HR, hazard ratio; 95% CI, 95% confidence interval; WD, well differentiated; MD, moderately differentiated; PD, poorly differentiated; LN, lymph node study group. 9 However, we detected no relationship between bile duct resection and the postoperative complication rate documented by our study, even though bile duct resection always required bilioenteric anastomosis.
Adverse effects of bile duct resection were almost always limited to the immediate postoperative period.
Recurrence of gallbladder cancer is more likely to involve a distant site and frequently occurs in early-stage disease. 19, 20 The peritoneum, liver and retroperitoneal lymph nodes tend to be the most common recurrence sites of a primary gallbladder cancer. 20 This recurrence pattern has tended to obscure the potential beneficial effect of bile duct resection in obviating a local recurrence. Moreover, patients with advanced cancer received adjuvant therapy, which has reported favorable results with regard to the survival benefits for gallbladder cancer. 21, 22 The recurrence rate in the BDR group was not significantly different from that of the BDNR group in this study. To estimate the relationship between the recurrence rate and bile duct resection, the effectiveness of bile duct resection for accurate lymph node dissection must be evaluated further.
About half of the patients who participated in this study received adjuvant therapy. Thirty-three patients in the BDR group and 22 patients in BDNR group belonged to homogenous adjuvant treatment regimen, should be considered viable treatment options, for therapeutic and diagnostic purposes, and to gain further insights into survival benefits.
In conclusion, advanced T-stage, LN metastasis, and LN count ＜6 were the independent prognostic factors for overall survival and disease-free survival in patients with T2 and T3 gallbladder cancer. The BDR group had more lymph nodes retrieved vs. the BDNR group, and bile duct resection did not increase complication rate. The role of bile duct resection may be limited to improved staging and without affording any actual long-term survival benefit, based upon the current study. However, without any documented, significant increase in morbidity of the BDR group, bile duct resection should be actively considered as in patients with suspicious invasion around hepatoduodenal ligament.
